(Q44022504)

29 November 2017

title

The role of apoptosis, cell proliferation index, bcl-2, and p53 in glioblastoma prognosis (English)

1 reference

29 November 2017

1 reference

Marlise de Castro Ribeiro

series ordinal

1

1 reference

29 November 2017

Lígia M Barbosa Coutinho

series ordinal

2

1 reference

29 November 2017

Arlete Hilbig

series ordinal

3

1 reference

29 November 2017

publication date

23 June 2004

1 reference

Arquivos de Neuro-Psiquiatria

29 November 2017

published in

1 reference

29 November 2017

volume

62

1 reference

29 November 2017

issue

2A

1 reference

29 November 2017

page(s)

262-270

1 reference

Survival of patients with glioblastoma multiforme is not influenced by altered expression of p16, p53, EGFR, MDM2 or Bcl-2 genes

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2004000200014

Prognostic value of tumour associated antigen immunoreactivity and apoptosis in cerebral glioblastomas: an analysis of 168 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2004000200014

Apoptosis in cerebral astrocytic tumours and its relationship to expression of the bcl-2 and p53 proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2004000200014

Analysis of proliferation and apoptosis in brain gliomas: prognostic and clinical value

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2004000200014

Apoptosis and cell proliferation in human neuroepithelial tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2004000200014

Analysis of proliferation markers and p53 expression in gliomas of astrocytic origin: relationships and prognostic value.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2004000200014

Apoptosis and p53 expression in human gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2004000200014

bcl-2 protein expression in astrocytomas in relation to patient survival and p53 gene status

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2004000200014

Patient age, histologic features, and length of survival in patients with glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2004000200014

Prognostic scoring in adult astrocytic tumors using patient age, histopathological grade, and DNA histogram type

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2004000200014

Apoptosis in astrocytic neoplasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2004000200014

Cell death and oxidative stress in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2004000200014

Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2004000200014

p53 mutation, expression, and DNA ploidy in evolving gliomas: evidence for two pathways of progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2004000200014

Image cytometric measurement of nuclear proliferation markers (MIB-1, PCNA) in astrocytomas. Prognostic significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2004000200014

BCL-2 family protein expression in human malignant glioma: a clinical-pathological correlative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2004000200014

10.1590/S0004-282X2004000200014

21 January 2018

Identifiers

DOI

1 reference

29 November 2017

1 reference